Date published: 2026-4-24

1-800-457-3801

SCBT Portrait Logo
Seach Input

C20orf118 Activators

TBC/LysM-associated domain-containing 2 (TBC1D2) is a protein encoded by the TBC1D2 gene in humans. This protein belongs to the TBC (Tre-2/Bub2/Cdc16) domain family, which is known for its role in regulating cell signaling pathways, particularly those associated with membrane trafficking and signal transduction. The TBC domain typically functions as a GTPase-activating protein (GAP) for small GTPases of the Rab family, which are key regulators of vesicle trafficking in eukaryotic cells.The TBC1D2 protein is characterized by the presence of a TBC domain and a LysM (Lysin motif) domain. The LysM domain is often associated with bacterial cell wall degradation and has been implicated in peptidoglycan binding, suggesting a potential role in recognizing or interacting with carbohydrate moieties. This combination of domains within TBC1D2 suggests a unique function that may bridge membrane trafficking with specific molecular recognition processes.

Although the precise cellular functions of TBC1D2 are not fully understood, the protein is thought to participate in the regulation of membrane dynamics and signal transduction pathways. By acting on Rab GTPases, TBC1D2 could influence vesicular transport pathways, including endocytosis and exocytosis, which are vital for maintaining cellular homeostasis, nutrient uptake, and signal dissemination.TBC1D2's involvement in such fundamental processes makes it a subject of interest in the study of cellular logistics and communication. Dysregulation of these pathways could have significant consequences, potentially leading to a variety of cellular dysfunctions or diseases.

SEE ALSO...

Items 1 to 10 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$63.00
$158.00
$326.00
233
(4)

Rapamycin inhibits the mTOR pathway, which is involved in cell growth and metabolism, and may indirectly influence TBC1D2.

Metformin

657-24-9sc-507370
10 mg
$79.00
2
(0)

Metformin activates AMP-activated protein kinase (AMPK) and may impact TBC1D2 through metabolic pathways.

Wortmannin

19545-26-7sc-3505
sc-3505A
sc-3505B
1 mg
5 mg
20 mg
$67.00
$223.00
$425.00
97
(3)

Wortmannin is a potent inhibitor of phosphoinositide 3-kinases (PI3K) and might affect TBC1D2 by modulating PI3K/AKT signaling.

U-0126

109511-58-2sc-222395
sc-222395A
1 mg
5 mg
$64.00
$246.00
136
(2)

U0126 is an inhibitor of MEK, a key component of the MAPK/ERK pathway, potentially affecting TBC1D2.

Trichostatin A

58880-19-6sc-3511
sc-3511A
sc-3511B
sc-3511C
sc-3511D
1 mg
5 mg
10 mg
25 mg
50 mg
$152.00
$479.00
$632.00
$1223.00
$2132.00
33
(3)

TSA, an inhibitor of histone deacetylases, impacts gene expression and chromatin remodeling, potentially influencing TBC1D2.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$123.00
$400.00
148
(1)

LY294002, another PI3K inhibitor, could affect TBC1D2 activity by modulating PI3K/AKT signaling.

Rosiglitazone

122320-73-4sc-202795
sc-202795A
sc-202795C
sc-202795D
sc-202795B
25 mg
100 mg
500 mg
1 g
5 g
$120.00
$326.00
$634.00
$947.00
$1259.00
38
(1)

Rosiglitazone, a PPAR-gamma agonist, affects glucose metabolism and insulin sensitivity, potentially influencing TBC1D2.

Curcumin

458-37-7sc-200509
sc-200509A
sc-200509B
sc-200509C
sc-200509D
sc-200509F
sc-200509E
1 g
5 g
25 g
100 g
250 g
1 kg
2.5 kg
$37.00
$69.00
$109.00
$218.00
$239.00
$879.00
$1968.00
47
(1)

Curcumin, with anti-inflammatory and antioxidant properties, might impact TBC1D2 indirectly through these mechanisms.

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
$90.00
$349.00
284
(5)

SB203580, a p38 MAPK inhibitor, could influence TBC1D2 activity by affecting stress response pathways.

2-Deoxy-D-glucose

154-17-6sc-202010
sc-202010A
1 g
5 g
$70.00
$215.00
26
(2)

2-Deoxy-D-glucose, a glycolysis inhibitor, might affect TBC1D2 through metabolic stress pathways.